TERT and thyroid gland carcinoma: Considering the above, TERT promoter mutational screening of a follicular cell-derived thyroid carcinoma specimen is a highly specific method for the proper identification of cases at risk of future recurrences, albeit displaying a low sensitivity in well-differentiated lesions.